The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

OBJECTIVE: To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy. PATIENTS AND METHODS: This randomized, double-blind, phase IIIb, noninferiority study, enrolled mal...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Urol
Hlavní autoři: Batista, Jose E., Kölbl, Heinz, Herschorn, Sender, Rechberger, Tomasz, Cambronero, Javier, Halaska, Michael, Coppell, Alex, Kaper, Mathilde, Huang, Moses, Siddiqui, Emad
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580095/
https://ncbi.nlm.nih.gov/pubmed/26445596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215589250
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky